QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

Background: Observational studies have suggested increased arrhythmic and cardiovascular risk with the combination use of hydroxychloroquine (HCQ) and azithromycin in patients with coronavirus disease 2019 (COVID-19). Objective: The arrhythmic safety profile of HCQ monotherapy, which remains under i...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Arun R. Sridhar, MBBS, MPH, Neal A. Chatterjee, MD, MSc, Basil Saour, MD, Dan Nguyen, MD, Elizabeth A. Starnes, ARNP, Christine Johnston, MD, MPH, Margaret L. Green, MD, MPH, Gregory A. Roth, MD, Jeanne E. Poole, MD, FHRS
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Elsevier 2020-08-01
Sraith:Heart Rhythm O2
Ábhair:
Coronavirus
Electrocardiogram
Hydroxychloroquine
QT interval
Ventricular arrhythmia
Rochtain ar líne:http://www.sciencedirect.com/science/article/pii/S2666501820300751

Ar líne

http://www.sciencedirect.com/science/article/pii/S2666501820300751

Míreanna comhchosúla